$1.11
9.02% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US8964383066
Symbol
TRIB

Trinity Biotech Plc Sponsored ADR Class A Stock price

$1.13
-0.80 41.45% 1M
-0.56 33.14% 6M
-1.02 47.32% YTD
-0.75 39.81% 1Y
-7.87 87.44% 3Y
-3.92 77.62% 5Y
-83.12 98.66% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.09 7.38%
ISIN
US8964383066
Symbol
TRIB
Sector

Key metrics

Market capitalization $12.85m
Enterprise Value $103.73m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.75
P/S ratio (TTM) P/S ratio 0.22
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -3.76%
Revenue (TTM) Revenue $59.13m
EBIT (operating result TTM) EBIT $-10.46m
Free Cash Flow (TTM) Free Cash Flow $-15.19m
Cash position $2.84m
EPS (TTM) EPS $-2.26
P/E forward negative
P/S forward 0.21
EV/Sales forward 1.67
Short interest 2.43%
Show more

Is Trinity Biotech Plc Sponsored ADR Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Trinity Biotech Plc Sponsored ADR Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Trinity Biotech Plc Sponsored ADR Class A:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Trinity Biotech Plc Sponsored ADR Class A:

Buy
100%

Financial data from Trinity Biotech Plc Sponsored ADR Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
59 59
4% 4%
100%
- Direct Costs 40 40
4% 4%
67%
20 20
4% 4%
33%
- Selling and Administrative Expenses 24 24
25% 25%
40%
- Research and Development Expense 4.21 4.21
5% 5%
7%
-8.55 -8.55
46% 46%
-14%
- Depreciation and Amortization 1.90 1.90
4% 4%
3%
EBIT (Operating Income) EBIT -10 -10
41% 41%
-18%
Net Profit -20 -20
29% 29%
-34%

In millions USD.

Don't miss a Thing! We will send you all news about Trinity Biotech Plc Sponsored ADR Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Trinity Biotech Plc Sponsored ADR Class A Stock News

Neutral
Seeking Alpha
11 days ago
Trinity Biotech Plc (NASDAQ:TRIB ) Q3 2024 Earnings Conference Call November 15, 2024 10:00 AM ET Company Participants Eric Ribner - Investor Relations John Gillard – President, Chief Executive Officer Louise Tallon - Chief Financial Officer Conference Call Participants James Sidoti - Sidoti & Company Paul Nouri – Noble Equity Funds Operator Greetings. Welcome to the Trinity Biotech Third Quart...
Neutral
GlobeNewsWire
11 days ago
Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% Y/Y Reiterates guidance to achieve approximately $20 million of annualized run-rate EBITDASO1 on annualized run-rate revenues of approximately $75 million by Q2 2025 Reiterates guidance to achieve 2024 sales revenue for TrinS...
Neutral
GlobeNewsWire
12 days ago
Conference Call Scheduled for Friday, November 15, 2024 at 10:00 AM ET Conference Call Scheduled for Friday, November 15, 2024 at 10:00 AM ET
More Trinity Biotech Plc Sponsored ADR Class A News

Company Profile

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Head office Ireland
CEO John Gillard
Employees 380
Founded 1992
Website www.trinitybiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today